Related Experiment Videos
Low-dose aspirin therapy in obstetrics
1Institute of Obstetrics and Gynecology, Erasmus University Medical School, Rotterdam, The Netherlands.
Current Opinion in Obstetrics & Gynecology
|April 1, 1995
Summary
Low-dose aspirin helps prevent pre-eclampsia in high-risk pregnant women. While its effect on fetal growth is minimal, low-dose aspirin is safe for mothers, fetuses, and newborns.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Perinatal Medicine
Background:
- Pre-eclampsia is a serious pregnancy complication.
- Identifying effective preventive strategies for high-risk pregnancies is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose aspirin for preventing pre-eclampsia.
- To assess the impact of low-dose aspirin on fetal growth retardation.
Main Methods:
- Analysis of four large controlled clinical trials.
- Inclusion of over 13,000 pregnant women at high risk for pre-eclampsia.
Main Results:
- Low-dose aspirin demonstrated a preventive benefit for pre-eclampsia in high-risk women.
- A small preventive effect was observed for fetal growth retardation.
- No therapeutic benefits of low-dose aspirin were established.
Conclusions:
- Low-dose aspirin is beneficial in preventing pre-eclampsia for high-risk pregnancies.
- The drug is considered safe for maternal, fetal, and neonatal health.
- Further research may explore its limited role in fetal growth concerns.